Skip to main content
Retour
Watch Compare

BIOXYTRAN, INC

Qualité des données : 83%
BIXT
OTC Manufacturing Chemicals
0,04 €
▼ 0,00 € (-2,63%)
Cap. Boursière: 4,50 M
Prix
0,04 €
Cap. Boursière
4,50 M
Fourchette du Jour
0,04 € — 0,04 €
Fourchette 52 Semaines
0,03 € — 0,20 €
Volume
89 500
Ouverture 0,04 €
Moyenne 50J / 200J
0,04 €
15,53% below
Moyenne 50J / 200J
0,07 €
46,06% below

Quick Summary

Points Clés

Negative free cash flow of -247 174,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,00
Interest Coverage-9,44

Valorisation

PE (TTM)
-2,13
En dessous de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,1 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -2,11 M
ROE N/A ROA -1391,19%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -247 174,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,00
Interest Coverage -9,44 Asset Turnover N/A
Working Capital -3,05 M Tangible Book Value -3,05 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,13 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5,49%
Market Cap 4,50 M Enterprise Value 4,50 M
Per Share
EPS (Diluted TTM) -0,03 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 11,70%
SBC-Adj. FCF -255 590 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -2,37 M -4,28 M -2,46 M -4,53 M -2,54 M
EPS (Diluted) -0,02 -0,03 — — —
Gross Profit — — — — —
Operating Income -2,22 M -3,82 M -2,13 M -4,21 M -1,27 M
EBITDA — — — — —
R&D Expenses 112 337,0 1,15 M 977 768,0 2,01 M 544 519,0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 84 240,0 — 2,02 M 236 577,0 1,01 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 138 694,0 137 638,0 370 936,0 119 290,0 326 403,0
Total Liabilities 1,93 M 3,25 M 3,66 M 3,28 M 2,27 M
Shareholders' Equity -1,79 M -3,11 M -3,29 M -3,16 M -1,94 M
Total Debt 48 000,0 — — — —
Cash & Equivalents — — — — —
Current Assets 5 154,0 26 086,0 295 401,0 72 358,0 316 403,0
Current Liabilities 1,93 M 3,25 M 3,66 M 3,28 M 2,27 M